DLC1 and breast carcinoma: Scholz et al suggests that PKD-mediated DLC1 phosphorylation at S327 and S431 residues can facilitate DLC1-14-3-3 interaction, followed by masking the potential NLS and sequestrating DLC1 in the cytosol in breast cancer cells [17].